Tapewire

Nasdaq · USD

CNSY

CERENOME, INC.

Export transactions ↓
Tapewire entity
7637
SEC CIK
0001095981
Parsed reports
179

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2023 Filed Mar 7, 2023 00:40 UTC PurchaseSeries F Preferred Stock 1 $1,000.00 $1,000.00
Disclosure

SEC source: 0001209191-23-016526 · doc4.xml · nonDerivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:32 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 104,404 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010651 · doc4.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,404

Underlying: Common Stock · 104,404 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:32 UTC GrantStock Option (Right to Buy) · Derivative 20,182 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010652 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,182

Underlying: Common Stock · 20,182 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:30 UTC GrantStock Option (Right to Buy) · Derivative 20,182 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010639 · doc4.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,182

Underlying: Common Stock · 20,182 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:30 UTC
LaFrance Norman D.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 74,981 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010638 · doc4.xml · derivative · entry 1

LaFrance Norman D. · CIK 0001397768 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,981

Underlying: Common Stock · 74,981 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:30 UTC GrantStock Option (Right to Buy) · Derivative 20,182 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010640 · doc4.xml · derivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,182

Underlying: Common Stock · 20,182 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:30 UTC GrantStock Option (Right to Buy) · Derivative 20,182 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010637 · doc4.xml · derivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,182

Underlying: Common Stock · 20,182 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:30 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 483,824 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001209191-23-010636 · doc4.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 483,824

Underlying: Common Stock · 483,824 shares

Expires 2033-02-15

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
December 30, 2022 Filed Jan 5, 2023 00:56 UTC SaleCommon Stock 1,500 $0.31 $472.05
Disclosure

SEC source: 0001209191-23-001447 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

F1 · price: (1) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3141 to $0.3185 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 15, 2022 Filed Jun 16, 2022 10:05 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.65 $3,240.00
Disclosure

SEC source: 0001209191-22-037240 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,580

Read SEC document
June 02, 2022 Filed Jun 6, 2022 11:30 UTC PurchaseCommon Stock 15,000 $0.57 $8,589.00
Disclosure

SEC source: 0001209191-22-034420 · doc4.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Read SEC document
May 17, 2022 Filed May 19, 2022 20:15 UTC PurchaseCommon Stock 30,000 $0.55 $16,500.00
Disclosure

SEC source: 0001209191-22-030494 · doc4.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Read SEC document
April 26, 2022 Filed Apr 27, 2022 11:00 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $0.69 $3,450.00
Disclosure

SEC source: 0001209191-22-025718 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,080

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6605 to $0.6919 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
April 26, 2022 Filed Apr 27, 2022 11:00 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 3,000 $0.67 $2,016.00
Disclosure

SEC source: 0001209191-22-025719 · doc4.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,230

Read SEC document
April 26, 2022 Filed Apr 28, 2022 11:00 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 2,500 $0.68 $1,710.25
Disclosure

SEC source: 0001209191-22-025901 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,580

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.6841 or $0.6879 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 11:15 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 2,000 $1.10 $2,199.80
Disclosure

SEC source: 0001209191-22-015201 · doc4.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,230

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.0998 or $1.00 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 11, 2021 Filed Mar 28, 2022 22:59 UTC Amendment
LaFrance Norman D.CHIEF MEDICAL OFFICER
GrantStock Option (right to buy shares of common stock) · Derivative 120,000 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0000899243-22-012518 · doc4a.xml · derivative · entry 1

LaFrance Norman D. · CIK 0001397768 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2031-11-11

F1 · derivative.exercise_date: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 10:15 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 1,000 $1.86 $1,864.30
Disclosure

SEC source: 0001209191-21-062868 · doc4.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,230

Read SEC document
November 01, 2021 Filed Nov 25, 2021 02:09 UTC
LaFrance Norman D.CHIEF MEDICAL OFFICER
GrantStock Option (right to buy shares of common stock) · Derivative 120,000 $0.00 Strike: $120,000.00 $0.00
Disclosure

SEC source: 0000899243-21-046120 · doc4.xml · derivative · entry 1

LaFrance Norman D. · CIK 0001397768 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2031-11-11

F1 · derivative.exercise_date: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.

Read SEC document
October 27, 2021 Filed Oct 28, 2021 10:15 UTC PurchaseCommon Stock 12,500 $1.72 $21,500.00
Disclosure

SEC source: 0001209191-21-061858 · doc4.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Read SEC document
October 26, 2021 Filed Oct 27, 2021 10:15 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 2,500 $1.66 $4,149.75
Disclosure

SEC source: 0001209191-21-061724 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,080

Read SEC document
October 26, 2021 Filed Oct 27, 2021 10:15 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 2,000 $1.67 $3,338.80
Disclosure

SEC source: 0001209191-21-061723 · doc4.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,230

Read SEC document
September 13, 2021 Filed Sep 15, 2021 11:30 UTC PurchaseCommon Stock 7,000 $1.86 $13,010.90
Disclosure

SEC source: 0001209191-21-056096 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.8499 to $1.859 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
July 28, 2021 Filed Jul 29, 2021 22:35 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 2,244 $1.91 $4,285.82
Disclosure

SEC source: 0001209191-21-048660 · doc4.xml · nonDerivative · entry 2

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,230

Read SEC document
July 27, 2021 Filed Jul 29, 2021 22:35 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 1,986 $2.05 $4,071.30
Disclosure

SEC source: 0001209191-21-048660 · doc4.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,986

Read SEC document
June 11, 2021 Filed Jun 12, 2021 00:43 UTC GrantStock Option (Right to Buy) · Derivative 6,336 $0.00 Strike: $2.88 $0.00
Disclosure

SEC source: 0001209191-21-040096 · doc4.xml · derivative · entry 2

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,336

Underlying: Common Stock · 6,336 shares

Expires 2031-06-11

F2 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
June 11, 2021 Filed Jun 12, 2021 00:43 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $2.88 $0.00
Disclosure

SEC source: 0001209191-21-040096 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-11

F1 · derivative.exercise_date: Options vest in equal monthly installments over 36 months.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:18 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 200,771 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036243 · doc4.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,771

Underlying: Common Stock · 200,771 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 6,336 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036242 · doc4.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,336

Underlying: Common Stock · 6,336 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:17 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (right to buy) · Derivative 100,197 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036241 · doc4.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,197

Underlying: Common Stock · 100,197 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 6,336 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036240 · doc4.xml · derivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,336

Underlying: Common Stock · 6,336 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:16 UTC GrantStock Option (Right to Buy) · Derivative 6,336 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036238 · doc4.xml · derivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,336

Underlying: Common Stock · 6,336 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:16 UTC GrantStock Option (Right to Buy) · Derivative 6,336 $0.00 Strike: $2.25 $0.00
Disclosure

SEC source: 0001209191-21-036237 · doc4.xml · derivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,336

Underlying: Common Stock · 6,336 shares

Expires 2031-05-25

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
April 30, 2021 Filed May 3, 2021 10:15 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 2,183 $2.28 $4,970.04
Disclosure

SEC source: 0001209191-21-029409 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,580

Read SEC document
March 04, 2021 Filed Mar 5, 2021 11:15 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 2,500 $2.50 $6,250.00
Disclosure

SEC source: 0001209191-21-018052 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,397

Read SEC document
March 03, 2021 Filed Mar 4, 2021 11:15 UTC PurchaseCommon Stock 3,000 $2.42 $7,260.00
Disclosure

SEC source: 0001209191-21-017597 · doc4.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:05 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 88,314 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001209191-21-011788 · doc4.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,314

Underlying: Common Stock · 88,314 shares

Expires 2031-02-16

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:05 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (right to buy) · Derivative 66,625 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001209191-21-011787 · doc4.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,625

Underlying: Common Stock · 66,625 shares

Expires 2031-02-16

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
December 10, 2020 Filed Dec 14, 2020 11:05 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 2,500 $1.99 $4,975.00
Disclosure

SEC source: 0001209191-20-063108 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,867

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.99 to $2.00 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 12:00 UTC
HEDRICK MARC HChief Executive Officer
PurchaseCommon Stock 2,200 $2.14 $4,708.00
Disclosure

SEC source: 0001209191-20-061011 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,367

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.15 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 10:05 UTC PurchaseCommon Stock 3,000 $2.49 $7,464.90
Disclosure

SEC source: 0001209191-20-048319 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
August 13, 2020 Filed Aug 14, 2020 10:05 UTC PurchaseCommon Stock 10,000 $2.80 $28,000.00
Disclosure

SEC source: 0001209191-20-046715 · doc4.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
August 12, 2020 Filed Aug 13, 2020 10:00 UTC
HEDRICK MARC HChief Executive Officer
PurchaseCommon Stock 4,000 $2.58 $10,318.40
Disclosure

SEC source: 0001209191-20-046503 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,167

Read SEC document
August 12, 2020 Filed Aug 13, 2020 10:05 UTC PurchaseCommon Stock 10,000 $2.52 $25,200.00
Disclosure

SEC source: 0001209191-20-046504 · doc4.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
June 25, 2020 Filed Jun 30, 2020 00:50 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-20-039325 · doc4.xml · derivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-06-25

F1 · derivative.exercise_date: The options vest over two years in equal 1/24th increments on each monthly anniversary of the issuance.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 00:49 UTC
HEDRICK MARC HChief Executive Officer
GrantStock Option (Right to Buy) · Derivative 140,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-20-039322 · doc4.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2030-06-25

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 00:47 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-20-039319 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-06-25

F1 · derivative.exercise_date: The options vest over two years in equal 1/24th increments on each monthly anniversary of the issuance.

Read SEC document
June 25, 2020 Filed Jun 30, 2020 00:46 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-20-039316 · doc4.xml · derivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-06-26

F1 · derivative.exercise_date: The options vest over two years in equal 1/24th increments on each monthly anniversary of the issuance.

Read SEC document
June 25, 2020 Filed Jul 1, 2020 13:55 UTC GrantStock Option (Right to Buy) · Derivative 34,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001209191-20-039563 · doc4.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires 2030-06-25

F1 · derivative.exercise_date: The options vest in equal 1/19th increments on the 9th of every month with the first 1/19th increment vesting on July 9, 2020 and the last 1/19th increment vesting on January 9, 2022.

Read SEC document
June 22, 2020 Filed Jun 23, 2020 23:10 UTC
HEDRICK MARC HChief Executive Officer
PurchaseCommon Stock 5,000 $2.10 $10,500.00
Disclosure

SEC source: 0001209191-20-038639 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.